speb/financial-data huggingface dataset:
ORGN balance_sheet (quarterly, 2025-09-30) — Share Issued: 5017768.00
ORGN income_statement (quarterly, 2025-09-30) — Special Income Charges: -210000.00
ORGN cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 2245000.00
ORGN balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 294987000.00
ORGN balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 294936000.00
ORGN income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 177030.00
ORGN income_statement (quarterly, 2025-09-30) — Tax Provision: 78000.00
ORGN income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.21
ORGN balance_sheet (quarterly, 2025-09-30) — Total Assets: 327345000.00
ORGN balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 294987000.00
ORGN balance_sheet (quarterly, 2025-09-30) — Total Debt: 5673000.00
ORGN balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 294987000.00
ORGN income_statement (quarterly, 2025-09-30) — Total Expenses: 21381000.00
ORGN balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 32358000.00
ORGN balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 243210000.00
ORGN balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 19071000.00
ORGN income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -16934000.00
ORGN income_statement (quarterly, 2025-09-30) — Total Unusual Items: 843000.00
ORGN income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 843000.00
ORGN balance_sheet (quarterly, 2025-09-30) — Working Capital: 70848000.00
ORGN income_statement (quarterly, 2025-09-30) — Write Off: 210000.00
ORGN income_statement (annual, 2025-12-31) — +Operating Expense: 63998000.00
ORGN income_statement (quarterly, 2025-12-31) — +Operating Expense: 15843000.00
ORGN income_statement (annual, 2025-12-31) — +Total Revenue: 18922000.00
ORGN income_statement (quarterly, 2025-12-31) — +Total Revenue: 3022000.00
ORGN balance_sheet (annual, 2025-12-31) — Accounts Payable: 3568000.00
ORGN balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 3568000.00
ORGN balance_sheet (annual, 2025-12-31) — Accounts Receivable: 13049000.00
ORGN balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 13049000.00
ORGN balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -28654000.00
ORGN balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -28654000.00
ORGN balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 402378000.00
ORGN balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 402378000.00
ORGN balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -828000.00
ORGN balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -828000.00
ORGN cash_flow (annual, 2025-12-31) — Amortization Of Securities: -139000.00
ORGN cash_flow (quarterly, 2025-12-31) — Amortization Of Securities: -47000.00
ORGN cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 195636000.00
ORGN cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: 178816000.00
ORGN balance_sheet (annual, 2025-12-31) — Assets Held For Sale Current: 9126000.00
ORGN balance_sheet (quarterly, 2025-12-31) — Assets Held For Sale Current: 9126000.00
ORGN income_statement (annual, 2025-12-31) — Basic Average Shares: 4940007.00
ORGN income_statement (quarterly, 2025-12-31) — Basic Average Shares: 5036621.00
ORGN income_statement (annual, 2025-12-31) — Basic EPS: -50.55
ORGN income_statement (quarterly, 2025-12-31) — Basic EPS: -38.54
ORGN cash_flow (annual, 2025-12-31) — Beginning Cash Position: 56307000.00
ORGN cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 34061000.00
ORGN cash_flow (annual, 2025-12-31) — Capital Expenditure: -30207000.00
ORGN cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -9109000.00
ORGN balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 3839000.00
ORGN balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 3839000.00
ORGN balance_sheet (annual, 2025-12-31) — Capital Stock: 15000.00
ORGN balance_sheet (quarterly, 2025-12-31) — Capital Stock: 15000.00
ORGN balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 32923000.00
ORGN balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 32923000.00
ORGN balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 53468000.00
ORGN balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 53468000.00
ORGN cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 10659000.00
ORGN cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 16678000.00
ORGN cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -1068000.00
ORGN cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -8947000.00
ORGN cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -32793000.00
ORGN cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -8921000.00
ORGN cash_flow (annual, 2025-12-31) — Change In Account Payable: -1160000.00
ORGN cash_flow (quarterly, 2025-12-31) — Change In Account Payable: -1033000.00
ORGN cash_flow (annual, 2025-12-31) — Change In Accrued Expense: 1529000.00
ORGN cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: 262000.00
ORGN cash_flow (annual, 2025-12-31) — Change In Inventory: 182000.00
ORGN cash_flow (quarterly, 2025-12-31) — Change In Inventory: -49000.00
ORGN cash_flow (annual, 2025-12-31) — Change In Other Current Assets: 213000.00
ORGN cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: 53000.00
ORGN cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: -508000.00
ORGN cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: -367000.00
ORGN cash_flow (annual, 2025-12-31) — Change In Payable: -1160000.00
ORGN cash_flow (quarterly, 2025-12-31) — Change In Payable: -1033000.00
ORGN cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 369000.00
ORGN cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: -771000.00
ORGN cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: -272000.00
ORGN cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: -403000.00
ORGN cash_flow (annual, 2025-12-31) — Change In Receivables: 5810000.00
ORGN cash_flow (quarterly, 2025-12-31) — Change In Receivables: 2655000.00
ORGN cash_flow (annual, 2025-12-31) — Change In Working Capital: 5794000.00
ORGN cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 1118000.00
ORGN cash_flow (annual, 2025-12-31) — Changes In Cash: -23202000.00
ORGN cash_flow (quarterly, 2025-12-31) — Changes In Cash: -1190000.00
ORGN balance_sheet (annual, 2025-12-31) — Common Stock: 15000.00
ORGN balance_sheet (quarterly, 2025-12-31) — Common Stock: 15000.00
ORGN balance_sheet (annual, 2025-12-31) — Common Stock Equity: 104211000.00
ORGN balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 104211000.00
ORGN balance_sheet (annual, 2025-12-31) — Construction In Progress: 44070000.00
ORGN balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 44070000.00
ORGN income_statement (annual, 2025-12-31) — Cost Of Revenue: 18381000.00
ORGN income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 2933000.00
ORGN balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 4947000.00
ORGN balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 4947000.00
ORGN balance_sheet (annual, 2025-12-31) — Current Assets: 80876000.00
ORGN balance_sheet (quarterly, 2025-12-31) — Current Assets: 80876000.00
ORGN balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 306000.00
ORGN balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 306000.00
ORGN balance_sheet (annual, 2025-12-31) — Current Debt: 19481000.00
ORGN balance_sheet (quarterly, 2025-12-31) — Current Debt: 19481000.00
ORGN balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 19787000.00
ORGN balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 19787000.00
ORGN balance_sheet (annual, 2025-12-31) — Current Liabilities: 28533000.00
ORGN balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 28533000.00
ORGN cash_flow (annual, 2025-12-31) — Deferred Income Tax: 621000.00
ORGN cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: 410000.00
ORGN cash_flow (annual, 2025-12-31) — Deferred Tax: 621000.00
ORGN cash_flow (quarterly, 2025-12-31) — Deferred Tax: 410000.00
ORGN cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 11175000.00
ORGN cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 2843000.00
ORGN income_statement (annual, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 11175000.00
ORGN income_statement (quarterly, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 2843000.00
ORGN cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 11175000.00
ORGN cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 2843000.00
ORGN income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 11175000.00
ORGN income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 2843000.00
ORGN balance_sheet (annual, 2025-12-31) — Derivative Product Liabilities: 167000.00
ORGN balance_sheet (quarterly, 2025-12-31) — Derivative Product Liabilities: 167000.00
ORGN income_statement (annual, 2025-12-31) — Diluted Average Shares: 4940007.00
ORGN income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 5036621.00
ORGN income_statement (annual, 2025-12-31) — Diluted EPS: -50.55
ORGN income_statement (quarterly, 2025-12-31) — Diluted EPS: -38.54
ORGN income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -249698000.00
ORGN income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -194128000.00
ORGN income_statement (annual, 2025-12-31) — EBIT: -248954000.00
ORGN income_statement (quarterly, 2025-12-31) — EBIT: -193747000.00
ORGN income_statement (annual, 2025-12-31) — EBITDA: -237779000.00
ORGN income_statement (quarterly, 2025-12-31) — EBITDA: -190904000.00
ORGN cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: -182000.00
ORGN cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: 52000.00
ORGN cash_flow (annual, 2025-12-31) — End Cash Position: 32923000.00
ORGN cash_flow (quarterly, 2025-12-31) — End Cash Position: 32923000.00
ORGN cash_flow (annual, 2025-12-31) — Financing Cash Flow: 10659000.00
ORGN cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 16678000.00
ORGN balance_sheet (annual, 2025-12-31) — Finished Goods: 49000.00
ORGN balance_sheet (quarterly, 2025-12-31) — Finished Goods: 49000.00
ORGN cash_flow (annual, 2025-12-31) — Free Cash Flow: -63000000.00
ORGN cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -18030000.00
ORGN cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: -4156000.00
ORGN cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: -381000.00
ORGN income_statement (annual, 2025-12-31) — Gain On Sale Of Security: 8398000.00
ORGN income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: 1157000.00
ORGN balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -10357000.00
ORGN balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -10357000.00
ORGN income_statement (annual, 2025-12-31) — General And Administrative Expense: 39074000.00
ORGN income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 9158000.00
ORGN balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 32000.00
ORGN balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 32000.00
ORGN balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 13877000.00
ORGN balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 13877000.00
ORGN balance_sheet (annual, 2025-12-31) — Gross PPE: 104655000.00
ORGN balance_sheet (quarterly, 2025-12-31) — Gross PPE: 104655000.00
ORGN income_statement (annual, 2025-12-31) — Gross Profit: 541000.00
ORGN income_statement (quarterly, 2025-12-31) — Gross Profit: 89000.00
ORGN cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 0.00
ORGN cash_flow (quarterly, 2025-12-31) — Income Tax Paid Supplemental Data: -26000.00
ORGN income_statement (annual, 2025-12-31) — Interest Expense: 123000.00
ORGN income_statement (quarterly, 2025-12-31) — Interest Expense: 17000.00
ORGN income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 123000.00
ORGN income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 17000.00
ORGN cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 171000.00
ORGN cash_flow (quarterly, 2025-12-31) — Interest Paid Supplemental Data: 0.00
ORGN balance_sheet (annual, 2025-12-31) — Inventory: 684000.00
ORGN balance_sheet (quarterly, 2025-12-31) — Inventory: 684000.00
ORGN balance_sheet (annual, 2025-12-31) — Invested Capital: 128078000.00
ORGN balance_sheet (quarterly, 2025-12-31) — Invested Capital: 128078000.00
ORGN cash_flow (annual, 2025-12-31) — Investing Cash Flow: -1068000.00
ORGN cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -8947000.00
ORGN cash_flow (annual, 2025-12-31) — Issuance Of Debt: 15000000.00
ORGN balance_sheet (annual, 2025-12-31) — Land And Improvements: 13337000.00
ORGN balance_sheet (quarterly, 2025-12-31) — Land And Improvements: 13337000.00
ORGN balance_sheet (annual, 2025-12-31) — Leases: 4766000.00
ORGN balance_sheet (quarterly, 2025-12-31) — Leases: 4766000.00
ORGN balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 3533000.00
ORGN balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 3533000.00
ORGN balance_sheet (annual, 2025-12-31) — Long Term Debt: 4386000.00
ORGN balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 4386000.00
ORGN balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 7919000.00
ORGN balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 7919000.00
ORGN cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 15000000.00
ORGN cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -6272000.00
ORGN cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: 0.00
ORGN balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 31547000.00
ORGN balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 31547000.00
ORGN income_statement (annual, 2025-12-31) — Net Income: -249698000.00
ORGN income_statement (quarterly, 2025-12-31) — Net Income: -194128000.00
ORGN income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -249698000.00
ORGN income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -194128000.00
ORGN income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -249698000.00
ORGN income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -194128000.00
ORGN income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -249698000.00
ORGN income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -194128000.00
ORGN income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -249698000.00
ORGN income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -194128000.00
ORGN cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -249698000.00
ORGN cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -194128000.00
ORGN income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -249698000.00
ORGN income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -194128000.00
ORGN income_statement (annual, 2025-12-31) — Net Interest Income: -123000.00
ORGN income_statement (quarterly, 2025-12-31) — Net Interest Income: -17000.00
ORGN cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: 26681000.00
ORGN cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: -179000.00
ORGN cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 8728000.00
ORGN cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: 15000000.00
ORGN cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 8728000.00
ORGN cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: 15000000.00
ORGN income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -123000.00
ORGN income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -17000.00
ORGN cash_flow (annual, 2025-12-31) — Net Other Financing Charges: 1678000.00
ORGN balance_sheet (annual, 2025-12-31) — Net PPE: 76001000.00
ORGN balance_sheet (quarterly, 2025-12-31) — Net PPE: 76001000.00
ORGN cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -27749000.00
ORGN cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -8768000.00
ORGN balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 104179000.00
ORGN balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 104179000.00
ORGN balance_sheet (annual, 2025-12-31) — Non Current Deferred Assets: 0.00
ORGN balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Assets: 0.00
ORGN balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Assets: 0.00
ORGN balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 0.00
ORGN income_statement (annual, 2025-12-31) — Normalized EBITDA: -53003000.00
ORGN income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -13245000.00
ORGN income_statement (annual, 2025-12-31) — Normalized Income: -103724960.00
ORGN income_statement (quarterly, 2025-12-31) — Normalized Income: -53777390.00
ORGN cash_flow (annual, 2025-12-31) — Operating Cash Flow: -32793000.00
ORGN cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -8921000.00
ORGN cash_flow (annual, 2025-12-31) — Operating Gains Losses: -4156000.00
ORGN cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -381000.00
ORGN income_statement (annual, 2025-12-31) — Operating Income: -63457000.00
ORGN income_statement (quarterly, 2025-12-31) — Operating Income: -15754000.00
ORGN income_statement (annual, 2025-12-31) — Operating Revenue: 18922000.00
ORGN income_statement (quarterly, 2025-12-31) — Operating Revenue: 3022000.00
ORGN balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 5173883.00
ORGN balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 5173883.00
ORGN balance_sheet (annual, 2025-12-31) — Other Current Assets: 2448000.00
ORGN balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 2448000.00
ORGN balance_sheet (annual, 2025-12-31) — Other Current Borrowings: 19481000.00
ORGN balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 19481000.00
ORGN balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 231000.00
ORGN balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 231000.00
ORGN balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: -10357000.00
ORGN balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: -10357000.00
ORGN income_statement (annual, 2025-12-31) — Other Gand A: 39074000.00
ORGN income_statement (quarterly, 2025-12-31) — Other Gand A: 9158000.00
ORGN income_statement (annual, 2025-12-31) — Other Income Expense: -185497000.00
ORGN income_statement (quarterly, 2025-12-31) — Other Income Expense: -177993000.00
ORGN balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 32000.00
ORGN balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 32000.00
ORGN cash_flow (annual, 2025-12-31) — Other Non Cash Items: -1684000.00
ORGN cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 163000.00
ORGN balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 751000.00
ORGN balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 751000.00
ORGN balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 16830000.00
ORGN balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 16830000.00
ORGN income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: -721000.00
ORGN income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: -334000.00
ORGN balance_sheet (annual, 2025-12-31) — Other Properties: 10935000.00
ORGN balance_sheet (quarterly, 2025-12-31) — Other Properties: 10935000.00
ORGN balance_sheet (annual, 2025-12-31) — Other Receivables: 2101000.00
ORGN balance_sheet (quarterly, 2025-12-31) — Other Receivables: 2101000.00
ORGN balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 20545000.00
ORGN balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 20545000.00
ORGN balance_sheet (annual, 2025-12-31) — Payables: 3568000.00
ORGN balance_sheet (quarterly, 2025-12-31) — Payables: 3568000.00
ORGN balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 8515000.00
ORGN balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 8515000.00
ORGN balance_sheet (annual, 2025-12-31) — Preferred Stock: 0.00
ORGN balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 0.00
ORGN income_statement (annual, 2025-12-31) — Pretax Income: -249077000.00
ORGN income_statement (quarterly, 2025-12-31) — Pretax Income: -193764000.00
ORGN cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 253000.00
ORGN cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 0.00
ORGN balance_sheet (annual, 2025-12-31) — Properties: 0.00
ORGN balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
ORGN cash_flow (annual, 2025-12-31) — Provisionand Write Offof Assets: 744000.00
ORGN cash_flow (quarterly, 2025-12-31) — Provisionand Write Offof Assets: 185000.00
ORGN cash_flow (annual, 2025-12-31) — Purchase Of Investment: -1067964000.00
ORGN cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -221747000.00
ORGN cash_flow (annual, 2025-12-31) — Purchase Of PPE: -30207000.00
ORGN cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -9109000.00
ORGN balance_sheet (annual, 2025-12-31) — Raw Materials: 635000.00
ORGN balance_sheet (quarterly, 2025-12-31) — Raw Materials: 635000.00
ORGN balance_sheet (annual, 2025-12-31) — Receivables: 15150000.00
ORGN balance_sheet (quarterly, 2025-12-31) — Receivables: 15150000.00
ORGN income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 18381000.00
ORGN income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 2933000.00
ORGN income_statement (annual, 2025-12-31) — Reconciled Depreciation: 11175000.00
ORGN income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 2843000.00
ORGN cash_flow (annual, 2025-12-31) — Repayment Of Debt: -6272000.00
ORGN cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: 0.00
ORGN income_statement (annual, 2025-12-31) — Research And Development: 13749000.00
ORGN income_statement (quarterly, 2025-12-31) — Research And Development: 3842000.00
ORGN income_statement (annual, 2025-12-31) — Restructuring And Mergern Acquisition: -2462000.00
ORGN income_statement (quarterly, 2025-12-31) — Restructuring And Mergern Acquisition: 0.00
ORGN balance_sheet (annual, 2025-12-31) — Retained Earnings: -287825000.00
ORGN balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -287825000.00
ORGN cash_flow (annual, 2025-12-31) — Sale Of Investment: 1094645000.00
ORGN cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 221568000.00
ORGN cash_flow (annual, 2025-12-31) — Sale Of PPE: 2458000.00
ORGN cash_flow (quarterly, 2025-12-31) — Sale Of PPE: 341000.00
ORGN income_statement (annual, 2025-12-31) — Selling General And Administration: 39074000.00
ORGN income_statement (quarterly, 2025-12-31) — Selling General And Administration: 9158000.00
ORGN balance_sheet (annual, 2025-12-31) — Share Issued: 5173883.00
ORGN balance_sheet (quarterly, 2025-12-31) — Share Issued: 5173883.00
ORGN income_statement (annual, 2025-12-31) — Special Income Charges: -193174000.00
ORGN income_statement (quarterly, 2025-12-31) — Special Income Charges: -178816000.00
ORGN cash_flow (annual, 2025-12-31) — Stock Based Compensation: 8914000.00
ORGN cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 2100000.00
ORGN balance_sheet (annual, 2025-12-31) — Stockholders Equity: 104211000.00
ORGN balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 104211000.00
ORGN balance_sheet (annual, 2025-12-31) — Tangible Book Value: 104179000.00
ORGN balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 104179000.00
ORGN income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: -38802960.00
ORGN income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -37308390.00
ORGN income_statement (annual, 2025-12-31) — Tax Provision: 621000.00
ORGN income_statement (quarterly, 2025-12-31) — Tax Provision: 364000.00
ORGN income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.21
ORGN income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.21
ORGN balance_sheet (annual, 2025-12-31) — Total Assets: 157660000.00
ORGN balance_sheet (quarterly, 2025-12-31) — Total Assets: 157660000.00
ORGN balance_sheet (annual, 2025-12-31) — Total Capitalization: 108597000.00
ORGN balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 108597000.00
ORGN balance_sheet (annual, 2025-12-31) — Total Debt: 27706000.00
ORGN balance_sheet (quarterly, 2025-12-31) — Total Debt: 27706000.00
ORGN balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 104211000.00
ORGN balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 104211000.00
ORGN income_statement (annual, 2025-12-31) — Total Expenses: 82379000.00
ORGN income_statement (quarterly, 2025-12-31) — Total Expenses: 18776000.00
ORGN balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 53449000.00
ORGN balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 53449000.00
ORGN balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 76784000.00
ORGN balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 76784000.00
ORGN balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 24916000.00
ORGN balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 24916000.00
ORGN income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -259093000.00
ORGN income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -194570000.00
ORGN income_statement (annual, 2025-12-31) — Total Unusual Items: -184776000.00
ORGN income_statement (quarterly, 2025-12-31) — Total Unusual Items: -177659000.00
ORGN income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -184776000.00
ORGN income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -177659000.00
ORGN balance_sheet (annual, 2025-12-31) — Working Capital: 52343000.00
ORGN balance_sheet (quarterly, 2025-12-31) — Working Capital: 52343000.00
ORGN income_statement (annual, 2025-12-31) — Write Off: 195636000.00
ORGN income_statement (quarterly, 2025-12-31) — Write Off: 178816000.00
ORGN income_statement (quarterly, 2026-03-31) — +Operating Expense: 16651000.00
ORGN income_statement (quarterly, 2026-03-31) — +Total Revenue: 477000.00
ORGN balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 1331000.00
ORGN balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 5362000.00
ORGN balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -29406000.00
ORGN balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 404667000.00
ORGN balance_sheet (quarterly, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -5448000.00
ORGN cash_flow (quarterly, 2026-03-31) — Amortization Of Securities: -19000.00
ORGN cash_flow (quarterly, 2026-03-31) — Asset Impairment Charge: 0.00
ORGN balance_sheet (quarterly, 2026-03-31) — Assets Held For Sale Current: 9125000.00
ORGN income_statement (quarterly, 2026-03-31) — Basic Average Shares: 5377854.00
ORGN income_statement (quarterly, 2026-03-31) — Basic EPS: -3.28
ORGN cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 32923000.00
ORGN cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -6969000.00
ORGN balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 3765000.00
ORGN balance_sheet (quarterly, 2026-03-31) — Capital Stock: 15000.00
ORGN balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 19191000.00
ORGN balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 32648000.00
ORGN cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -8640000.00
ORGN cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: 244000.00
ORGN cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -4867000.00
ORGN cash_flow (quarterly, 2026-03-31) — Change In Account Payable: 460000.00
ORGN cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: -193000.00
ORGN cash_flow (quarterly, 2026-03-31) — Change In Inventory: 2000.00
ORGN cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: -965000.00
ORGN cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: -32000.00
ORGN cash_flow (quarterly, 2026-03-31) — Change In Payable: 460000.00
ORGN cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: 267000.00
ORGN cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: 1322000.00
ORGN cash_flow (quarterly, 2026-03-31) — Change In Receivables: 3580000.00
ORGN cash_flow (quarterly, 2026-03-31) — Change In Working Capital: 4174000.00
ORGN cash_flow (quarterly, 2026-03-31) — Changes In Cash: -13263000.00
ORGN balance_sheet (quarterly, 2026-03-31) — Common Stock: 15000.00
ORGN balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 88320000.00
ORGN balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 47939000.00
ORGN income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 337000.00
ORGN balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 4717000.00
ORGN balance_sheet (quarterly, 2026-03-31) — Current Assets: 50530000.00
ORGN balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 316000.00
ORGN balance_sheet (quarterly, 2026-03-31) — Current Debt: 11429000.00
ORGN balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 11745000.00
ORGN balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 19024000.00
ORGN cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: 0.00
ORGN cash_flow (quarterly, 2026-03-31) — Deferred Tax: 0.00
ORGN cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 1185000.00
ORGN income_statement (quarterly, 2026-03-31) — Depreciation Amortization Depletion Income Statement: 1185000.00
ORGN cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 1185000.00
ORGN income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 1185000.00
ORGN balance_sheet (quarterly, 2026-03-31) — Derivative Product Liabilities: 89000.00
ORGN income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 5377854.00
ORGN income_statement (quarterly, 2026-03-31) — Diluted EPS: -3.28
ORGN income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -17650000.00
ORGN income_statement (quarterly, 2026-03-31) — EBIT: -17634000.00
ORGN income_statement (quarterly, 2026-03-31) — EBITDA: -16449000.00
ORGN cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: -469000.00
ORGN cash_flow (quarterly, 2026-03-31) — End Cash Position: 19191000.00
ORGN cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -8640000.00
ORGN balance_sheet (quarterly, 2026-03-31) — Finished Goods: 49000.00
ORGN cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -11836000.00
ORGN cash_flow (quarterly, 2026-03-31) — Gain Loss On Investment Securities: -166000.00
ORGN income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: 689000.00
ORGN balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -10887000.00
ORGN income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 12708000.00
ORGN balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 24000.00
ORGN balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 10810000.00
ORGN balance_sheet (quarterly, 2026-03-31) — Gross PPE: 112212000.00
ORGN income_statement (quarterly, 2026-03-31) — Gross Profit: 140000.00
ORGN income_statement (quarterly, 2026-03-31) — Interest Expense: 16000.00
ORGN income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 16000.00
ORGN cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 0.00
ORGN balance_sheet (quarterly, 2026-03-31) — Inventory: 682000.00
ORGN balance_sheet (quarterly, 2026-03-31) — Invested Capital: 107403000.00
ORGN cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: 244000.00
ORGN balance_sheet (quarterly, 2026-03-31) — Land And Improvements: 13116000.00
ORGN balance_sheet (quarterly, 2026-03-31) — Leases: 4766000.00
ORGN balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 3449000.00
ORGN balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 7654000.00
ORGN balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 11103000.00
ORGN cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -8640000.00
ORGN balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 31037000.00
ORGN income_statement (quarterly, 2026-03-31) — Net Income: -17650000.00
ORGN income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -17650000.00
ORGN income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -17650000.00
ORGN income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -17650000.00
ORGN income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -17650000.00
ORGN cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -17650000.00
ORGN income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -17650000.00
ORGN income_statement (quarterly, 2026-03-31) — Net Interest Income: -16000.00
ORGN cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: 7177000.00
ORGN cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -8640000.00
ORGN cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -8640000.00
ORGN income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -16000.00
ORGN balance_sheet (quarterly, 2026-03-31) — Net PPE: 82806000.00
ORGN cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -6933000.00
ORGN cash_flow (quarterly, 2026-03-31) — Net Short Term Debt Issuance: 0.00
ORGN balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 88296000.00
ORGN income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -17138000.00
ORGN income_statement (quarterly, 2026-03-31) — Normalized Income: -18339000.00
ORGN cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -4867000.00
ORGN cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: -166000.00
ORGN income_statement (quarterly, 2026-03-31) — Operating Income: -16511000.00
ORGN income_statement (quarterly, 2026-03-31) — Operating Revenue: 477000.00
ORGN balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 5499307.00
ORGN balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 1126000.00
ORGN balance_sheet (quarterly, 2026-03-31) — Other Current Borrowings: 11429000.00
ORGN balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 1231000.00
ORGN balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -10887000.00
ORGN income_statement (quarterly, 2026-03-31) — Other Gand A: 12708000.00
ORGN income_statement (quarterly, 2026-03-31) — Other Income Expense: -1123000.00
ORGN balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 24000.00
ORGN cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 1941000.00
ORGN balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 1715000.00
ORGN balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 16539000.00
ORGN income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: -1812000.00
ORGN balance_sheet (quarterly, 2026-03-31) — Other Properties: 15354000.00
ORGN balance_sheet (quarterly, 2026-03-31) — Other Receivables: 1587000.00
ORGN balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 13457000.00
ORGN balance_sheet (quarterly, 2026-03-31) — Payables: 1331000.00
ORGN balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 6048000.00
ORGN balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 0.00
ORGN income_statement (quarterly, 2026-03-31) — Pretax Income: -17650000.00
ORGN balance_sheet (quarterly, 2026-03-31) — Properties: 0.00
ORGN cash_flow (quarterly, 2026-03-31) — Provisionand Write Offof Assets: 4620000.00
ORGN cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -128153000.00
ORGN cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -6969000.00
ORGN balance_sheet (quarterly, 2026-03-31) — Raw Materials: 633000.00
ORGN balance_sheet (quarterly, 2026-03-31) — Receivables: 6949000.00
ORGN income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 337000.00
ORGN income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 1185000.00
ORGN cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -8640000.00
ORGN income_statement (quarterly, 2026-03-31) — Research And Development: 2758000.00
ORGN balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -305475000.00
ORGN cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 135330000.00
ORGN cash_flow (quarterly, 2026-03-31) — Sale Of PPE: 36000.00
ORGN income_statement (quarterly, 2026-03-31) — Selling General And Administration: 12708000.00
ORGN balance_sheet (quarterly, 2026-03-31) — Share Issued: 5499307.00
ORGN cash_flow (quarterly, 2026-03-31) — Short Term Debt Payments: 0.00
ORGN income_statement (quarterly, 2026-03-31) — Special Income Charges: 0.00
ORGN cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 1048000.00
ORGN balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 88320000.00
ORGN balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 88296000.00
ORGN income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
ORGN income_statement (quarterly, 2026-03-31) — Tax Provision: 0.00
ORGN income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.00
ORGN balance_sheet (quarterly, 2026-03-31) — Total Assets: 135075000.00
ORGN balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 95974000.00
ORGN balance_sheet (quarterly, 2026-03-31) — Total Debt: 22848000.00
ORGN balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 88320000.00
ORGN income_statement (quarterly, 2026-03-31) — Total Expenses: 16988000.00
ORGN balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 46755000.00
ORGN balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 84545000.00
ORGN balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 27731000.00
ORGN income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: -16511000.00
ORGN income_statement (quarterly, 2026-03-31) — Total Unusual Items: 689000.00
ORGN income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 689000.00
ORGN balance_sheet (quarterly, 2026-03-31) — Working Capital: 31506000.00
ORGN income_statement (quarterly, 2026-03-31) — Write Off: 0.00
ORGO cash_flow (annual, 2021-12-31) — Common Stock Issuance: 0.00
ORGO balance_sheet (annual, 2021-12-31) — Current Debt: 2656000.00
ORGO balance_sheet (annual, 2021-12-31) — Current Deferred Liabilities: 1436000.00
ORGO income_statement (annual, 2021-12-31) — Interest Expense: 7236000.00
ORGO income_statement (annual, 2021-12-31) — Interest Expense Non Operating: 7236000.00
ORGO cash_flow (annual, 2021-12-31) — Issuance Of Debt: 73174000.00
ORGO balance_sheet (annual, 2021-12-31) — Long Term Debt: 70769000.00
ORGO cash_flow (annual, 2021-12-31) — Long Term Debt Issuance: 73174000.00
ORGO cash_flow (annual, 2021-12-31) — Net Business Purchase And Sale: 0.00
ORGO cash_flow (annual, 2021-12-31) — Net Intangibles Purchase And Sale: 0.00
ORGO cash_flow (annual, 2021-12-31) — Net Short Term Debt Issuance: -10000000.00
ORGO balance_sheet (annual, 2021-12-31) — Non Current Deferred Liabilities: 0.00
ORGO balance_sheet (annual, 2021-12-31) — Other Current Borrowings: 2656000.00
ORGO income_statement (annual, 2021-12-31) — Other Special Charges: 1883000.00
ORGO cash_flow (annual, 2021-12-31) — Purchase Of Business: 0.00
ORGO cash_flow (annual, 2021-12-31) — Purchase Of Intangibles: 0.00
ORGO income_statement (annual, 2021-12-31) — Restructuring And Mergern Acquisition: 0.00
ORGO income_statement (annual, 2022-12-31) — +Operating Expense: 323570000.00
ORGO income_statement (annual, 2022-12-31) — +Total Revenue: 450893000.00
ORGO balance_sheet (annual, 2022-12-31) — Accounts Payable: 32330000.00
ORGO balance_sheet (annual, 2022-12-31) — Accounts Receivable: 89450000.00
ORGO balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -62798000.00
ORGO balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 310957000.00
ORGO balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: -6362000.00
ORGO cash_flow (annual, 2022-12-31) — Amortization Cash Flow: 4883000.00
ORGO cash_flow (annual, 2022-12-31) — Amortization Of Intangibles: 4883000.00
ORGO cash_flow (annual, 2022-12-31) — Asset Impairment Charge: 0.00
ORGO income_statement (annual, 2022-12-31) — Basic Average Shares: 130070231.00
ORGO income_statement (annual, 2022-12-31) — Basic EPS: 0.12
ORGO cash_flow (annual, 2022-12-31) — Beginning Cash Position: 114528000.00
ORGO balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 4943000.00
ORGO cash_flow (annual, 2022-12-31) — Capital Expenditure: -33898000.00
ORGO balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 53022000.00
ORGO balance_sheet (annual, 2022-12-31) — Capital Stock: 13000.00
ORGO balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 102478000.00
ORGO balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 102478000.00
ORGO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: -2199000.00
ORGO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -33898000.00
ORGO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 24859000.00
ORGO cash_flow (annual, 2022-12-31) — Change In Account Payable: 3260000.00
ORGO cash_flow (annual, 2022-12-31) — Change In Accrued Expense: -11850000.00
ORGO cash_flow (annual, 2022-12-31) — Change In Inventory: -9410000.00
ORGO cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: 72000.00
ORGO cash_flow (annual, 2022-12-31) — Change In Other Working Capital: -7006000.00
ORGO cash_flow (annual, 2022-12-31) — Change In Payable: 3260000.00
ORGO cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: -8590000.00
ORGO cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: -378000.00
ORGO cash_flow (annual, 2022-12-31) — Change In Receivables: -8770000.00
ORGO cash_flow (annual, 2022-12-31) — Change In Working Capital: -34082000.00
ORGO cash_flow (annual, 2022-12-31) — Changes In Account Receivables: -8770000.00
ORGO cash_flow (annual, 2022-12-31) — Changes In Cash: -11238000.00
ORGO balance_sheet (annual, 2022-12-31) — Common Stock: 13000.00
ORGO balance_sheet (annual, 2022-12-31) — Common Stock Equity: 265669000.00
ORGO cash_flow (annual, 2022-12-31) — Common Stock Issuance: 0.00
ORGO cash_flow (annual, 2022-12-31) — Common Stock Payments: 0.00
ORGO balance_sheet (annual, 2022-12-31) — Construction In Progress: 65564000.00
ORGO income_statement (annual, 2022-12-31) — Cost Of Revenue: 105019000.00
ORGO balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 5783000.00
ORGO balance_sheet (annual, 2022-12-31) — Current Assets: 222609000.00
ORGO balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 11708000.00
ORGO balance_sheet (annual, 2022-12-31) — Current Debt: 4538000.00
ORGO balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 16246000.00
ORGO balance_sheet (annual, 2022-12-31) — Current Deferred Liabilities: 0.00
ORGO balance_sheet (annual, 2022-12-31) — Current Liabilities: 75023000.00
ORGO cash_flow (annual, 2022-12-31) — Deferred Income Tax: 1980000.00
ORGO cash_flow (annual, 2022-12-31) — Deferred Tax: 1980000.00
ORGO cash_flow (annual, 2022-12-31) — Depreciation: 13148000.00
ORGO cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 18031000.00
ORGO cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 18031000.00
ORGO income_statement (annual, 2022-12-31) — Diluted Average Shares: 132383152.00
ORGO income_statement (annual, 2022-12-31) — Diluted EPS: 0.12
ORGO income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 15532000.00
ORGO income_statement (annual, 2022-12-31) — EBIT: 22291000.00
ORGO income_statement (annual, 2022-12-31) — EBITDA: 40322000.00
ORGO cash_flow (annual, 2022-12-31) — End Cash Position: 103290000.00
ORGO cash_flow (annual, 2022-12-31) — Financing Cash Flow: -2199000.00
ORGO balance_sheet (annual, 2022-12-31) — Finished Goods: 11479000.00
ORGO cash_flow (annual, 2022-12-31) — Free Cash Flow: -9039000.00
ORGO cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of PPE: 4482000.00
ORGO balance_sheet (annual, 2022-12-31) — Goodwill: 28772000.00
ORGO balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 49561000.00
ORGO balance_sheet (annual, 2022-12-31) — Gross Accounts Receivable: 95812000.00
ORGO balance_sheet (annual, 2022-12-31) — Gross PPE: 208453000.00
ORGO income_statement (annual, 2022-12-31) — Gross Profit: 345874000.00
ORGO income_statement (annual, 2022-12-31) — Impairment Of Capital Assets: 0.00
ORGO cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 1201000.00
ORGO income_statement (annual, 2022-12-31) — Interest Expense: 2009000.00
ORGO income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 2009000.00
ORGO cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 2649000.00
ORGO balance_sheet (annual, 2022-12-31) — Inventory: 24783000.00
ORGO balance_sheet (annual, 2022-12-31) — Invested Capital: 336438000.00
ORGO cash_flow (annual, 2022-12-31) — Investing Cash Flow: -33898000.00
ORGO cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 0.00
ORGO cash_flow (annual, 2022-12-31) — Issuance Of Debt: 0.00
ORGO balance_sheet (annual, 2022-12-31) — Leases: 37607000.00
ORGO balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 41314000.00
ORGO balance_sheet (annual, 2022-12-31) — Long Term Debt: 66231000.00
ORGO balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 107545000.00
ORGO cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 0.00
ORGO cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -3013000.00
ORGO balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 57147000.00
ORGO cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: 0.00
ORGO cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 0.00
ORGO income_statement (annual, 2022-12-31) — Net Income: 15532000.00
ORGO income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 15532000.00
ORGO income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 15532000.00
ORGO income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 15532000.00
ORGO income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 15532000.00
ORGO cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 15532000.00
ORGO income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 15532000.00